Comparison of coronary atherosclerotic features in response to achieving LDL-C <55 mg/dl between non-diabetic and diabetic patients: insights from the REASSURE-NIRS registry

医学 内科学 糖尿病 罪魁祸首 血管内超声 心脏病学 钙化 动脉粥样硬化 传统PCI 心肌梗塞 内分泌学
作者
Takamasa Iwai,Y Katoka,Kota Murai,Hayato Hosoda,Satoshi Honda,Masashi Fujino,Shuichi Yoneda,Fumiyuki Otsuka,Kensaku Nishihira,Tomoaki Kanaya,Yasuhide Asaumi,Shunsuke Murata,Yoshihiro Miyamoto,Satoshi Yasuda,Teruo Noguchi
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:42 (Supplement_1)
标识
DOI:10.1093/eurheartj/ehab724.2563
摘要

Abstract Introduction Current ESC guideline recommends achieving LDL-C <1.4 mmol/l in very high-risk subjects. Despite fabvourable anti-atherosclerotic effects of lowering LDL-C, its efficacy is diminished in type 2 diabetic patients. Whether response of coronary atheroma to on-treatment LDL-C <1.4 mmol/l differs in diabetic and non-diabetic subjects has not been elucidated yet. Methods The REASSURE-NIRS registry is an on-going multi-center registry to enroll CAD subjects receiving PCI under the guidance of near-infrared spectroscopy/intravascular ultrasound (NIRS/IVUS: DualProTM, Nipro, Tokyo, Japan) imaging. Culprit lesions in 557 CAD patients who already received a statin were evaluated by NIRS/IVUS. Maximum 4-mm-lipid-core burden-index (maxLCBI4mm) and plaque calcification grade at culprit sites were measured. Calcification grade at each 1-mm cross-sectional image was defined as follows: calcium arc 0° = 0, 0–90° = 1, 90–180° = 2, 180–270° = 3, 270–360° = 4. MaxLCBI4mm and the averaged calcification grade were compared in diabetic and non-diabetic subjects stratified according to on-treatment LDL-C level, respectively. Result The proportion of diabetic (n=293, HbA1c; 6.9±0.9%) and non-diabetic patients (n=264) with on-treatment LDL-C <1.4 mmol/l was 8.54 and 16.67%, respectivey (p=0.01). In non-diabetic patients, achieving LDL-C <1.4mmol/L was associated with a lower maxLCBI4mm, whereas, in diabetic patients, maxLCBI4mm was numerically smaller under achieving LDL-C <1.4 mmol/l, but this comparison did not meet statistical significance (Figure 1). Furthermore, a greater degree of calcification grade in non-diabetic patients was observed in association with on-treatment LDL-C level (Figure 2). However, plaque calcification at diabetic coronary atheroma was not necessarily induced under achieving stricter LDL-C goal. Subgroup analysis demonstrated that diabetic patients with body mass index ≥25 (odds ratio = 0.15; 95% CI: 0.18–1.19, p=0.04), estimated glomerular filtration rate <60 (mL/min/1.73m2) (odds ratio = 0.31; 95% CI: 0.10–0.90, p=0.03) and non-insulin use (odds ratio = 0.36; 95% CI: 0.14–0.87, p=0.02) benefit from achieving LDL-C <1.4 mmol/l. Conclusion Achieving LDL-C <1.4 mmol/l was associated with more stabilized atheroma in non-diabetic patients with CAD, whereas these favourable effects were not observed in diabetic subjects. Our findings suggest the potential need to modify additional atherogenic risks for stabilizing diabetic coronary atheroma under achieving LDL-C <1.4 mmol/l. Funding Acknowledgement Type of funding sources: None. Figure 1Figure 2

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男的应助被大白采纳,获得10
1秒前
Owen的应助被可研小菜鸟采纳,获得10
1秒前
2秒前
chi2完成签到,获得积分10
2秒前
2秒前
fangzi完成签到,获得积分10
3秒前
3秒前
3秒前
yeo完成签到,获得积分10
4秒前
落寞的寒云完成签到,获得积分10
4秒前
TEXAS完成签到,获得积分10
4秒前
4秒前
bkagyin的应助被浅陌采纳,获得10
4秒前
4秒前
田様的应助被一叶知秋采纳,获得10
4秒前
陈天降低完成签到,获得积分10
5秒前
5秒前
大水桶发布了新的文献求助10
5秒前
咸鱼打滚完成签到,获得积分10
5秒前
xyc完成签到,获得积分10
7秒前
慕青的应助被鳗鱼水云采纳,获得10
7秒前
7秒前
LCFXR发布了新的文献求助10
8秒前
LL完成签到,获得积分10
8秒前
8秒前
micor发布了新的文献求助10
8秒前
8秒前
8秒前
8秒前
XialianWeng完成签到,获得积分10
9秒前
Hong发布了新的文献求助10
9秒前
zhawenchang发布了新的文献求助10
9秒前
xxy发布了新的文献求助10
10秒前
周舟发布了新的文献求助10
10秒前
laoying关注了科研通微信公众号
10秒前
第五彧轩发布了新的文献求助10
11秒前
苹果绝义完成签到,获得积分10
11秒前
11秒前
11秒前
小蘑菇的应助被魔幻雨梅采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8154161
求助须知:如何正确求助?哪些是违规求助? 9550701
关于积分的说明 21700590
捐赠科研通 7743260
什么是DOI,文献DOI怎么找? 3425651
关于科研通互助平台的介绍 2550861
邀请新用户注册赠送积分活动 2469363